Laminin, an extracellular matrix protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene.[7]
Upregulation of LAMA1 holds potential for treating LAMA2-related muscular dystrophy.[8][9]
âKemaladewi DU, Bassi PS, Erwood S, Al-Basha D, Gawlik KI, Lindsay K, et al. (August 2019). "A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene". Nature. 572 (7767): 125â130. doi:10.1038/s41586-019-1430-x. PMID 31341277.
âLiu Y, Tan D, Ma K, Luo H, Mao J, Luo J, et al. (October 2024). "Lama1 upregulation prolongs the lifespan of the dyH/dyH mouse model of LAMA2-related congenital muscular dystrophy". Journal of Genetics and Genomics = Yi Chuan Xue Bao. 51 (10): 1066â1078. doi:10.1016/j.jgg.2024.05.005. PMID 38777118.
Timpl R (October 1996). "Macromolecular organization of basement membranes". Current Opinion in Cell Biology. 8 (5): 618â624. doi:10.1016/S0955-0674(96)80102-5. PMIDÂ 8939648.
Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenbach J, et al. (October 1995). "Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy". Nature Genetics. 11 (2): 216â218. doi:10.1038/ng1095-216. PMID 7550355. S2CID 34969060.
Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K (September 1994). "Dystroglycan is a binding protein of laminin and merosin in peripheral nerve". FEBS Letters. 352 (1): 49â53. doi:10.1016/0014-5793(94)00917-1. PMIDÂ 7925941. S2CIDÂ 17529055.
Squarzoni S, Villanova M, Sabatelli P, Malandrini A, Toti P, Pini A, et al. (March 1997). "Intracellular detection of laminin alpha 2 chain in skin by electron microscopy immunocytochemistry: comparison between normal and laminin alpha 2 chain deficient subjects". Neuromuscular Disorders. 7 (2): 91â98. doi:10.1016/S0960-8966(96)00420-8. PMID 9131649. S2CID 140209385.
Mrowiec T, Melchar C, GÃģrski A (1998). "HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium". Archivum Immunologiae et Therapiae Experimentalis. 45 (2â3): 255â259. PMIDÂ 9597096.
Kuang W, Xu H, Vilquin JT, Engvall E (2000). "Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency". Laboratory Investigation; A Journal of Technical Methods and Pathology. 79 (12): 1601â1613. PMIDÂ 10616210.
Pegoraro E, Fanin M, Trevisan CP, Angelini C, Hoffman EP (October 2000). "A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy". Neurology. 55 (8): 1128â1134. doi:10.1212/wnl.55.8.1128. PMIDÂ 11071490. S2CIDÂ 80274277.
McArthur CP, Wang Y, Heruth D, Gustafson S (2001). "Amplification of extracellular matrix and oncogenes in tat-transfected human salivary gland cell lines with expression of laminin, fibronectin, collagens I, III, IV, c-myc and p53". Archives of Oral Biology. 46 (6): 545â555. doi:10.1016/S0003-9969(01)00014-0. PMIDÂ 11311202.